Edition:
India

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

270.45INR
3:57pm IST
Change (% chg)

Rs-9.10 (-3.26%)
Prev Close
Rs279.55
Open
Rs278.75
Day's High
Rs278.75
Day's Low
Rs268.30
Volume
328,067
Avg. Vol
477,310
52-wk High
Rs334.70
52-wk Low
Rs182.70

Latest Key Developments (Source: Significant Developments)

India's Suven Life Sciences Sept-Quarter Profit Rises
Thursday, 14 Nov 2019 

Nov 14 (Reuters) - Suven Life Sciences Ltd ::SEPT-QUARTER CONSOL NET PROFIT 633.1 MILLION RUPEES VERSUS 38.7 MILLION RUPEES YEAR AGO.SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.74 BILLION RUPEES VERSUS 895.2 MILLION RUPEES YEAR AGO.  Full Article

India's Suven Life Sciences Dec-Qtr Net Profit Falls
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Suven Life Sciences Ltd ::DEC QUARTER NET PROFIT 252.3 MILLION RUPEES VERSUS PROFIT 346 MILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 1.50 RUPEES PER SHARE.DEC QUARTER REVENUE FROM OPERATIONS 1.29 BILLION RUPEES VERSUS 1.64 BILLION RUPEES YEAR AGO.  Full Article

Suven Life Sciences Gets Product Patents In New Zealand, Norway
Tuesday, 22 May 2018 

May 22 (Reuters) - Suven Life Sciences Ltd ::SAYS CO SECURES PRODUCT PATENTS IN NEW ZEALAND AND NORWAY.SUVEN LIFE SCIENCES SAYS PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS PATENTS ARE VALID THROUGH 2034 AND 2027.  Full Article

Suven Life Sciences Gets Product Patents In Australia, Eurasia And Europe
Wednesday, 9 May 2018 

May 9 (Reuters) - Suven Life Sciences Ltd ::SECURES PRODUCT PATENTS IN AUSTRALIA, EURASIA AND EUROPE.SAYS PATENTS ARE VALID THROUGH 2034.  Full Article

Suven Life Sciences Secures Product Patents In Canada, India
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Suven Life Sciences Ltd ::‍SAYS SECURES PRODUCT PATENTS IN CANADA AND INDIA.SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS CANADA AND INDIA PATENTS ARE VALID THROUGH 2034 AND 2028 ‍​RESPECTIVELY.  Full Article